WO2001087988A1 - Process for preparing chitosan particles - Google Patents

Process for preparing chitosan particles Download PDF

Info

Publication number
WO2001087988A1
WO2001087988A1 PCT/US2001/015182 US0115182W WO0187988A1 WO 2001087988 A1 WO2001087988 A1 WO 2001087988A1 US 0115182 W US0115182 W US 0115182W WO 0187988 A1 WO0187988 A1 WO 0187988A1
Authority
WO
WIPO (PCT)
Prior art keywords
chitosan
gel
particles
suspension
agitation
Prior art date
Application number
PCT/US2001/015182
Other languages
French (fr)
Inventor
Henryk Struszczyk
Antoni Niekraszewicz
Alojzy Urbanowski
Magdalena Kucharska
Maria Wisniewska-Wrona
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Priority to JP2001585205A priority Critical patent/JP2004501235A/en
Priority to AU2001263046A priority patent/AU2001263046A1/en
Priority to EP01937295A priority patent/EP1280829A1/en
Priority to CA002407584A priority patent/CA2407584A1/en
Publication of WO2001087988A1 publication Critical patent/WO2001087988A1/en
Priority to US10/278,534 priority patent/US6740752B2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/12Powdering or granulating
    • C08J3/14Powdering or granulating by precipitation from solutions
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/14Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
    • A01N43/16Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Definitions

  • the present invention relates to a process for preparing particles of chitosan.
  • Chitosan particles in this form which are prepared according to the process herein are "activated" in the sense that they are especially useful for providing plant care benefits.
  • Chitosan is a modified carbohydrate polymer derived from the chitin component of the shells of crustaceans such as crabs, shrimp and cuttlefish. Chitosan is used for a wide variety of purposes including plant care, cosmetics additives, food and nutrition supplements and medical care uses.
  • the procedure is a batch process which requires at least 12 - 24 hours for a production cycle.
  • the single batches of the product are lacking homogeneity.
  • the product has a distinct tendency toward degradation and its sorption capacity is rather poor resulting from the relatively low degree of development of the inner surface of the chitosan particles.
  • Polish Patent No. 164,247 and Finnish Patent No. 83,426 both disclose a continuous method for producing microcrystallme chitosan.
  • a solution of chitosan in aqueous acids and/or their salts is introduced to a reactor along with an aqueous solution of alkali metal hydroxides or salts.
  • this alkaline suspension of the formed microcrystallme chitosan particles is continuously removed from the reactor.
  • the alkaline solution may also be introduced directly to a recirculation system.
  • This method has several drawbacks including a yield below 90%, and realization of chitosan agglomerates with an average particle size above 1 ⁇ m and water retention value below 5000%.
  • the water retention value is an indication of the development of the inner surface.
  • it is not possible to control the molecular, supermolecular and morphological structure of the chitosan particles produced.
  • This continuous process also causes a substantial decrease of the average molecular weight of the generated microcrystallme chitosan as result of intensive degradation effects.
  • the present invention provides a process for preparing particles of "microcrystallme” chitosan in the form of an aqueous suspension of such particles.
  • the chitosan particles in the suspension are "activated” in the sense that the chitosan material in this form is especially useful for a number of purposes including in particular the provision of a variety of plant care benefits.
  • an aqueous solution is formed, generally containing at least 0.001% and preferably from 0.01% to 10.0% by weight of chitosan which can be provided by any conventional chitosan source.
  • This solution contains organic or inorganic acids and/or salts of such acids in an amount sufficient to maintain the solution at a pH which is low enough to completely solubilize the chitosan.
  • the aqueous solution of the first step is partially neutralized by adding a neutralizing agent while subjecting the solution to shear agitation. The neutralizing agent addition and the agitation are sufficient to convert the solution into a continuous gel phase having a pH of from 5.0 to 6.9
  • the partially neutralized gel formed in the previous step is maintained under shear agitation for at least 10 seconds after the gel phase has been formed in order to homogenize the gel phase.
  • This agitated homogenized gel is then further neutralized under continuing agitation by addition of more neutralizing agent sufficient to raise the pH within the homogenized gel phase to above 6.9, preferably above 7.3. Agitation is preferably continued for at least another 10 seconds after this elevated pH is reached. This then forms a gel-like suspension of discrete particles of activated microcrystalline chitosan having desirable properties.
  • the aqueous solution formed in the initial step can be filtered prior to neutralization to remove insoluble matter such as may have been introduced with the chitosan source.
  • the chitosan particles of the eventually formed gel-like suspension may be washed, e.g., with water, to remove such materials such water soluble salts.
  • the chitosan particles produced by the process of this invention are characterized by having an average particle size of from 2 to 20 ⁇ m.
  • Preferably also such particles further have a water solubility of at least 90% at pH 6 after 24 hours.
  • an aqueous solution of chitosan is formed.
  • This can be accomplished by combining chitosan with an aqueous solution containing organic or inorganic acids or their salts.
  • Such acids can include, for example, acetic acid, lactic acid, salicylic acid, hydrochloric acid, and the like.
  • Sufficient acid or salt thereof must be utilized to maintain this solution at a pH wherein the chitosan is essentially completely dissolved, i.e., solubilized. Agitation sufficient to facilitate chitosan dissolution may be utilized.
  • chitosan Any conventional source of chitosan may be utilized to form the chitosan solution.
  • Such chitosan sources may be those derived from shellfish or may be fungally derived.
  • Commercially available chitosan sources are marketed, for example, under the tradenames "Chitosan” by Nanson, Inc. of Redmond, Washington , USA and “Chitoclear” by Primex Ingredients SA of Avaldsnes, Norway.
  • the chitosan is utilized to an extent which is sufficient to form a concentration of chitosan in the aqueous solution of at least 0.001% by weight. More preferably, the solution will contain from 0.01% to 10.0% by weight, most preferably from 0.01% to 1.5% by weight.
  • such a solution may optionally be filtered before further processing in order to remove therefrom any insoluble material which might remain therein.
  • insoluble material for example, may have been introduced into the solution from the chitosan source.
  • the chitosan solution formed in the first essential process step is partially neutralized. This is accomplished by adding a neutralizing agent to the solution while maintaining the solution under shear agitation.
  • Neutralization agents which can be used in this step include hydroxides such as sodium, potassium and ammonium hydroxides and their salts.
  • these neutralization agents are combined with the first step chitosan solution in the form of aqueous solutions having a neutralizing agent concentration of from 0.01% to 20% by weight.
  • Partial neutralization in this second essential process step is effected while the combined chitosan/neutralizing agent solution is maintained under shear agitation.
  • Both the addition of the neutralizing agent and the shear agitation should be sufficiently carried out in order to convert the solution into a continuous gel phase having a pH within the range of from 5.0 to 6.9.
  • shear agitation to the extent of from 10 to 1000 sec "1 (rpm) can be used.
  • the gel phase is next subjected to continued shear agitation in order to homogenize this gel phase.
  • continued shear agitation is carried out for a period of at least 10 seconds and preferably for a period of from 1 to 60 minutes.
  • shear agitation utilized at this point is applied to the extent of from 100 to 5000 sec "1 .
  • the homogenized gel phase from the previous step is further neutralized while still being subjected to shear agitation.
  • neutralizing agent is added to the extent needed to raise the pH within the gel to above 6.9, and preferably to within the range of 7.1 to 7.5, e.g., above 7.3. This generally occurs under shear agitation of from 10 to lOOOsec "1 .
  • high shear agitation 100 to 5000 sec "1 ) can be used to homogenize the suspension.
  • the same type and form of neutralizing agents as specified above for the partial neutralization step can be utilized in this further neutralization step.
  • the neutralizing agent used in this further neutralization step does not have to be identical to the neutralizing agent used in the partial neutralization step.
  • This further neutralization step produces a gel-like suspension of discrete particles of chitosan.
  • this suspension of particles at this point can be washed, e.g., with water, to remove therefrom any residual soluble salt impurities.
  • the chitosan particles in the suspension may also be concentrated, recovered and/or dried in conventional manner.
  • the process of this invention may be carried out in either a batch-wise or continuous format.
  • the sol form of the chitosan salt is transformed into gel.
  • nucleation points appear for the agglomerates of chitosan.
  • An agglomerate structure emerges and a physical-chemical modification of the initial gel form proceeds.
  • the final agglomerate structure of the chitosan particles forms.
  • the stabilization of the agglomerates of the physical/chemical modified chitosan particles proceeds in the final step of the process.
  • a controlled structure of the product is formed with respect to the molecular, supermolecular and morphological characteristics of the resulting material.
  • the chitosan particles produced by this invention are characterized herein as "microcrystalline” even though their degree of crystallinity is very low, and, in fact is much lower than the degree of crystallinity of commercial chitosan products which have a significant crystalline content. Perhaps more accurately, the particles herein can be characterized as "activated” given their utility in a number of contexts as described hereinafter.
  • the chitosan material of the particles which are produced has a modified specific molecular structure having specific molecular weight and degree of polydispersity. It also has a supermolecular structure having certain morphological characteristics which provide relatively high porosity and relatively high ability to retain water in a capillary system.
  • the modified chitosan can be prepared according to this invention with a yield of over 90%, usually 95-99.5%.
  • the material is highly homogenous and well reproducible. It has average molecular weight which is close to that of the initial chitosan with lowered molecular polydispersity.
  • the material also has a Water Retention Value (WRV) which is generally much higher than that for the starting chitosan. WRV will, in fact generally exceed 1000% and can even exceed 5000%, a value not attainable via previously known methods.
  • WRV Water Retention Value
  • the process of the instant invention permits realization of activated chitosan with a modified structure, in the form of a gel-like suspension, paste or powder.
  • the gel-like form is stable with attainable agglomerate sizes below l ⁇ m.
  • the average particle size of the chitosan particles in suspension will range from 2 to 20 ⁇ m.
  • these particles will have a water solubility of at least 90%, preferably 95%, at pH 6 after 24 hours.
  • the modified chitosan prepared according to the present invention can be applied in agriculture, medicine, pharmacy, veterinary medicine, chemical industry, health and beauty care products and environment protection.
  • the activated chitosan produced by this invention is particularly useful in the area of plant care.
  • a aqueous solution of sodium hydroxide With continual agitation at 60 rpm, a 0.25% aqueous solution of sodium hydroxide is introduced continuously through a metering pump to achieve pH 5.0 to 6.9 at which pH the chitosan salt is transformed from sol to gel with partial forming of the "microcrystalline" form.
  • the product obtained is purified as in Example I.
  • the chitosan produced is in the form of a white gel-like suspension with the following properties for the two trials as shown in Table 2:
  • a set of equipment consisting of a reactor equipped with agitator, metering pumps and a recirculation assembly with pump and an outlet for the intermediate product connected to a second reactor is used in this Example.
  • 1000 parts by wt of an aqueous solution containing 1.5% aqueous lactic acid and 1% chitosan with properties as in Example IV are introduced.
  • a 1.5 % solution of chitosan in lactic acid is continuously introduced with the rate of 1200 wt parts per hour.
  • a 0.75% NaOH solution is also introduced at a rate of 585 wt parts per hour which allows the pH to be kept at 6.7-6.9.
  • the gel which is produced is directed to the second reactor.
  • the mixture in the second reactor is homogenized at 4000 ⁇ m.
  • the average retention time in the reactor is 30 minutes.
  • the product obtained from the second reactor is purified as in Example I.
  • the resulting chitosan in the form of a white gel-like suspension is obtained with an output of

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Materials Engineering (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)

Abstract

Disclosed is a process for producing particles of the modified carbohydrate polymer chitosan. Such chitosan particles are 'activated' as a consequence of the specific steps used in the process. The process involves precipitation of dissolved chitosan from an acid solution thereof by the step-wise addition of neutralizing agent to the solution. A partial neutralization is carried out under shear agitation to form a continuous gel phase having a pH within the range of 5.0 to 6.9. This partially neutralized chitosan gel phase is then further subjected to shear agitation for at least 10 seconds to homogenize the gel phase. The homogenized gel phase is then further neutralized under shear agitation to a pH of above 6.9 to form a gel-like suspension of discrete chitosan particles. Chitosan particles in this form are useful in a number of contexts including, in particular, in the area of plant care.

Description

Process for Preparing Chitosan Particles
Technical Field
The present invention relates to a process for preparing particles of chitosan. Chitosan particles in this form which are prepared according to the process herein are "activated" in the sense that they are especially useful for providing plant care benefits.
Background of the Invention
Chitosan is a modified carbohydrate polymer derived from the chitin component of the shells of crustaceans such as crabs, shrimp and cuttlefish. Chitosan is used for a wide variety of purposes including plant care, cosmetics additives, food and nutrition supplements and medical care uses.
Both Polish Patent No. 125,995 and the periodical "Journal of Applied Polymer Science" Vol. 33 p. 177, 1987 disclose a method for producing a form of chitosan with a developed internal surface. This is done via a batch process in which the chitosan is periodically precipitated from its solutions in aqueous organic or inorganic acids or their salts by means of neutralization with hydroxides of alkali metals. The precipitation mixture is vigorously stirred. The precipitated chitosan in gel or suspension form is washed several times with water. This known method permits production of chitosan having a developed internal surface with a yield of 70 - 90% of theoretical. However, the procedure is a batch process which requires at least 12 - 24 hours for a production cycle. The single batches of the product are lacking homogeneity. The product has a distinct tendency toward degradation and its sorption capacity is rather poor resulting from the relatively low degree of development of the inner surface of the chitosan particles.
Polish Patent No. 164,247 and Finnish Patent No. 83,426 both disclose a continuous method for producing microcrystallme chitosan. In this method a solution of chitosan in aqueous acids and/or their salts is introduced to a reactor along with an aqueous solution of alkali metal hydroxides or salts. This results in formation of suspension of microcrystallme chitosan particles with a suspension pH > 7. Simultaneously, this alkaline suspension of the formed microcrystallme chitosan particles is continuously removed from the reactor. The alkaline solution may also be introduced directly to a recirculation system. This method has several drawbacks including a yield below 90%, and realization of chitosan agglomerates with an average particle size above 1 μm and water retention value below 5000%. The water retention value is an indication of the development of the inner surface. Moreover, it is not possible to control the molecular, supermolecular and morphological structure of the chitosan particles produced. This continuous process also causes a substantial decrease of the average molecular weight of the generated microcrystallme chitosan as result of intensive degradation effects.
Summary of the Invention
The present invention provides a process for preparing particles of "microcrystallme" chitosan in the form of an aqueous suspension of such particles. As a consequence of the specific steps used to carry out the process, the chitosan particles in the suspension are "activated" in the sense that the chitosan material in this form is especially useful for a number of purposes including in particular the provision of a variety of plant care benefits.
In the first step of the process herein, an aqueous solution is formed, generally containing at least 0.001% and preferably from 0.01% to 10.0% by weight of chitosan which can be provided by any conventional chitosan source. This solution contains organic or inorganic acids and/or salts of such acids in an amount sufficient to maintain the solution at a pH which is low enough to completely solubilize the chitosan. In the next step of the process, the aqueous solution of the first step is partially neutralized by adding a neutralizing agent while subjecting the solution to shear agitation. The neutralizing agent addition and the agitation are sufficient to convert the solution into a continuous gel phase having a pH of from 5.0 to 6.9
In the next process step, the partially neutralized gel formed in the previous step is maintained under shear agitation for at least 10 seconds after the gel phase has been formed in order to homogenize the gel phase. This agitated homogenized gel is then further neutralized under continuing agitation by addition of more neutralizing agent sufficient to raise the pH within the homogenized gel phase to above 6.9, preferably above 7.3. Agitation is preferably continued for at least another 10 seconds after this elevated pH is reached. This then forms a gel-like suspension of discrete particles of activated microcrystalline chitosan having desirable properties.
In preferred embodiments of the present process, the aqueous solution formed in the initial step can be filtered prior to neutralization to remove insoluble matter such as may have been introduced with the chitosan source. Also preferably the chitosan particles of the eventually formed gel-like suspension may be washed, e.g., with water, to remove such materials such water soluble salts.
Preferably the chitosan particles produced by the process of this invention are characterized by having an average particle size of from 2 to 20 μm. Preferably also such particles further have a water solubility of at least 90% at pH 6 after 24 hours.
Detailed Description of the Invention
In the first step of the process described above, an aqueous solution of chitosan is formed. This can be accomplished by combining chitosan with an aqueous solution containing organic or inorganic acids or their salts. Such acids can include, for example, acetic acid, lactic acid, salicylic acid, hydrochloric acid, and the like. Sufficient acid or salt thereof must be utilized to maintain this solution at a pH wherein the chitosan is essentially completely dissolved, i.e., solubilized. Agitation sufficient to facilitate chitosan dissolution may be utilized.
Any conventional source of chitosan may be utilized to form the chitosan solution. Such chitosan sources may be those derived from shellfish or may be fungally derived. Commercially available chitosan sources are marketed, for example, under the tradenames "Chitosan" by Nanson, Inc. of Redmond, Washington , USA and "Chitoclear" by Primex Ingredients SA of Avaldsnes, Norway.
The chitosan is utilized to an extent which is sufficient to form a concentration of chitosan in the aqueous solution of at least 0.001% by weight. More preferably, the solution will contain from 0.01% to 10.0% by weight, most preferably from 0.01% to 1.5% by weight.
After the aqueous chitosan solution has been formed in the first essential step of the process herein, such a solution may optionally be filtered before further processing in order to remove therefrom any insoluble material which might remain therein. Such insoluble material, for example, may have been introduced into the solution from the chitosan source.
In a second essential step of the process herein, the chitosan solution formed in the first essential process step is partially neutralized. This is accomplished by adding a neutralizing agent to the solution while maintaining the solution under shear agitation. Neutralization agents which can be used in this step include hydroxides such as sodium, potassium and ammonium hydroxides and their salts. Preferably these neutralization agents are combined with the first step chitosan solution in the form of aqueous solutions having a neutralizing agent concentration of from 0.01% to 20% by weight.
Partial neutralization in this second essential process step is effected while the combined chitosan/neutralizing agent solution is maintained under shear agitation. Both the addition of the neutralizing agent and the shear agitation should be sufficiently carried out in order to convert the solution into a continuous gel phase having a pH within the range of from 5.0 to 6.9. Typically shear agitation to the extent of from 10 to 1000 sec"1 (rpm) can be used.
After this continuous gel phase has been formed, the gel phase is next subjected to continued shear agitation in order to homogenize this gel phase. Generally such continued shear agitation is carried out for a period of at least 10 seconds and preferably for a period of from 1 to 60 minutes. Typically shear agitation utilized at this point is applied to the extent of from 100 to 5000 sec"1.
Next the homogenized gel phase from the previous step is further neutralized while still being subjected to shear agitation. In this step, neutralizing agent is added to the extent needed to raise the pH within the gel to above 6.9, and preferably to within the range of 7.1 to 7.5, e.g., above 7.3. This generally occurs under shear agitation of from 10 to lOOOsec"1. After the requisite pH is reached, high shear agitation (100 to 5000 sec"1) can be used to homogenize the suspension. The same type and form of neutralizing agents as specified above for the partial neutralization step can be utilized in this further neutralization step. Alternatively, the neutralizing agent used in this further neutralization step does not have to be identical to the neutralizing agent used in the partial neutralization step.
This further neutralization step produces a gel-like suspension of discrete particles of chitosan. Preferably this suspension of particles at this point can be washed, e.g., with water, to remove therefrom any residual soluble salt impurities. The chitosan particles in the suspension may also be concentrated, recovered and/or dried in conventional manner. The process of this invention may be carried out in either a batch-wise or continuous format.
In the process according to this invention, during the initial partial neutralization step, the sol form of the chitosan salt is transformed into gel. Simultaneously, nucleation points appear for the agglomerates of chitosan. Without being bound by theory, it is believed that the intensive agitation causes this. An agglomerate structure emerges and a physical-chemical modification of the initial gel form proceeds. Further on in the process during further neutralization, the final agglomerate structure of the chitosan particles forms. The stabilization of the agglomerates of the physical/chemical modified chitosan particles proceeds in the final step of the process. During this chitosan manufacturing procedure, a controlled structure of the product is formed with respect to the molecular, supermolecular and morphological characteristics of the resulting material.
The chitosan particles produced by this invention are characterized herein as "microcrystalline" even though their degree of crystallinity is very low, and, in fact is much lower than the degree of crystallinity of commercial chitosan products which have a significant crystalline content. Perhaps more accurately, the particles herein can be characterized as "activated" given their utility in a number of contexts as described hereinafter. The chitosan material of the particles which are produced has a modified specific molecular structure having specific molecular weight and degree of polydispersity. It also has a supermolecular structure having certain morphological characteristics which provide relatively high porosity and relatively high ability to retain water in a capillary system.
The modified chitosan can be prepared according to this invention with a yield of over 90%, usually 95-99.5%. The material is highly homogenous and well reproducible. It has average molecular weight which is close to that of the initial chitosan with lowered molecular polydispersity. The material also has a Water Retention Value (WRV) which is generally much higher than that for the starting chitosan. WRV will, in fact generally exceed 1000% and can even exceed 5000%, a value not attainable via previously known methods.
The process of the instant invention permits realization of activated chitosan with a modified structure, in the form of a gel-like suspension, paste or powder. The gel-like form is stable with attainable agglomerate sizes below lμm. Preferably, however, the average particle size of the chitosan particles in suspension will range from 2 to 20 μm. Preferably also these particles will have a water solubility of at least 90%, preferably 95%, at pH 6 after 24 hours.
The modified chitosan prepared according to the present invention can be applied in agriculture, medicine, pharmacy, veterinary medicine, chemical industry, health and beauty care products and environment protection. As indicated hereinbefore, the activated chitosan produced by this invention is particularly useful in the area of plant care.
The process of this invention, and the material produced thereby, are illustrated by following examples which do not limit the scope of the present invention.
Example I
800 parts by weight of a 1% aqueous solution of commercially available chitosan (Primex Chitoclear) in 2% acetic acid are introduced to a reactor equipped with an agitator. The initial polymer is characterized by: average molecular weight Mv = 550 kD, deacetylation degree DD = 80.6%, polydispersity degree Pd = 4.85, ash content 1.70%. At rotation speed 60 rpm of the agitator, a 1.5% aqueous solution of sodium hydroxide is introduced through a metering pump to achieve pH = 6.85 which is the turning point of the chitosan salt mixture from the sol to gel form. The gel so obtained is agitated for 5 minutes at 1000 pm. Thereafter the neutralization is continued with addition of the 1.5% aqueous sodium hydroxide at agitation speed 4000 rpm during next 5 minutes to attain pH = 7.5. Next the mixture is homogenized over 10 minutes. The chitosan obtained in a gel-like suspension is continuously washed with water. The suspension is next concentrated. 840 wt parts of chitosan are obtained in form of a white gel-like suspension with 0.94% concentration and with following characteristics: Mv = 488.9 kD, DD = 80.6%, WRV = 4500%, Pd = 4.45 and average size of the agglomerates 0.5 to 3 μm. Ash content is 0.32% wt.
Example II To a reactor, as in Example I, 1000 parts by wt are introduced of a 1% aqueous chitosan solution (with properties as in Example I) along with a 1.5% solution of lactic acid. With continual agitation at 120 rpm, a 0.75% aqueous solution of sodium hydroxide is continuously introduced through a metering pump to achieve pH 6.0 - 6.8. This results in the transformation of the chitosan salt from the sol form into gel and a partial formation of the chitosan form. The intermediate product obtained is homogenized for 1 minute at 1000 rpm followed further by 10 minutes of neutralization with the 0.75% aqueous sodium hydroxide solution at 4000 rpm to achieve pH = 7.5. This is followed by 5 minutes of homogenizing. The chitosan obtained in a gel-like suspension is purified as in Example I.
In this case 640 parts by wt of chitosan are obtained in the form of a white gel-like suspension with 1.5% concentration of the polymer and following characteristics: Mv = 491.5 kD, DD = 80.6%, WRV = 2300%, Pd = 4.88, ash content 0.1% and average agglomerate size = 0.5 - 5 μm
Example III
To a reactor as in Example I, 800 parts by weight are introduced of a 1% aqueous chitosan solution, with properties as in Example I, along with a 0.5% solution of lactic acid. With continual agitation at 90 rpm, a 0.25% aqueous solution of potassium hydroxide is continuously introduced through a metering pump to achieve pH = 6.9%. This results in the transformation of the chitosan salt from the sol form into gel. The intermediate product obtained is homogenized for 10 minutes at 1000 rpm, followed further by 1 minute of neutralization with the 0.25% aqueous potassium hydroxide solution at 4000 rpm to achieve pH = 7.4. The mixture is then homogenized for 15 minutes at the same agitator speed. The product obtained is purified as in Example I.
1020 parts by wt of chitosan are obtained in form of a white, gel-like suspension with 0.75% concentration of the polymer and the following characteristics: Mv = 398.2 kD, DD = 80.6%, WRV = 5200%, Pd = 4.52, ash content = 0.5% and average particle size in the 0.05- 10 μm range. Example IV
To a reactor as in Example I, 900 parts by wt of a 1% aqueous solution of chitosan (with following properties Mv = 328.2 kD, DD = 82.5%, Pd = 3.185 and ash content = 0.34%)) are introduced along with a 0.65% aqueous salicylic acid solution. With continual agitation at 60 rpm, a 0.25% aqueous solution of sodium hydroxide is introduced continuously through a metering pump to achieve pH 5.0 to 6.9 at which pH the chitosan salt is transformed from sol to gel with partial forming of the "microcrystalline" form. The intermediate product obtained is homogenized for 2 minutes at 4000 rpm, followed by 90 seconds of neutralization with 0.25% aqueous sodium hydroxide at the same agitation speed to achieve pH = 7.3. The homogenization is continued at that reaction pH = 7.3 for 5 minutes. The product obtained is purified as in Example I.
445 parts by wt of chitosan are obtained in the form of a white, gel-like suspension with 2.0%> concentration of polymer with the following characteristics: Mv = 327 kD, DD = 82.5%, WRV = 1380%, Pd = 3.05 ash content = 0.05% and average agglomerate size = 1-10 μm.
Example V
To a reactor as in Example I, 1000 parts by wt of a 1% aqueous solution of chitosan (with properties as in Example I) are introduced along with a 1.5% solution of lactic acid. With continual agitation at 100 rpm, a 0.75% solution of aqueous sodium hydroxide is continuously introduced through a metering pump to achieve pH 5.0 which allows the sol/gel transition to begin. The resulting gel is agitated for 5 minutes (Trial 1) or 30 minutes (Trial 2) at 4000 rpm followed by 1 minute of neutralization with 0.75% aqueous sodium hydroxide and simultaneous homogenizing at 4000 rpm to achieve pH = 7.2. The homogenization is continued for 10 minutes further at 4000 rpm. The chitosan obtained is purified as in Example I.
In both trials chitosan is obtained as a white gel-like suspension with properties as shown in Table 1 below: Table 1
Figure imgf000011_0001
Example VI
To a reactor as in Example I, 1000 parts by wt of a 1% aqueous solution of chitosan (properties as in Example I) are introduced along with a 1.5% solution of lactic acid. With continual agitation at 900 rpm, a 0.75% aqueous solution of sodium hydroxide is introduced through a metering pump to achieve pH 6.5 which allows the sol/gel transition. The generated gel is agitated at 4000 rpm for 5 minutes (Trial 1) and for 30 minutes (Trial 2), followed by 60 seconds of neutralization and simultaneous homogenizing at 4000 φm to achieve pH = 7.2. Under such conditions, homogenizing is continued for 10 minutes at 4000 φm. The chitosan obtained is purified as in Example I.
The chitosan produced is in the form of a white gel-like suspension with the following properties for the two trials as shown in Table 2:
Table 2
Example VII
A set of equipment consisting of a reactor equipped with agitator, metering pumps and a recirculation assembly with pump and an outlet for the intermediate product connected to a second reactor is used in this Example. To the first reactor, 1000 parts by wt of an aqueous solution containing 1.5% aqueous lactic acid and 1% chitosan with properties as in Example IV are introduced. With continual agitation at 1000 φm, a 0.75% aqueous solution of sodium hydroxide is continuously introduced to achieve a pH = 6.8 and to achieve the sol/gel transition. Next with the agitator running at 1000 φm, a 1.5 % solution of chitosan in lactic acid is continuously introduced with the rate of 1200 wt parts per hour. A 0.75% NaOH solution is also introduced at a rate of 585 wt parts per hour which allows the pH to be kept at 6.7-6.9. At the same time with the recirculation assembly switched on, the gel which is produced is directed to the second reactor. The gel in the second reactor is continuously neutralized to pH = 7.5 to form the activated chitosan. The mixture in the second reactor is homogenized at 4000 φm. The average retention time in the reactor is 30 minutes.
The product obtained from the second reactor is purified as in Example I. The resulting chitosan in the form of a white gel-like suspension is obtained with an output of
20 wt. parts per hour and has following characteristics: concentration = 1.94%, Mv =
315 kD, DD = 82.5%, Pd = 2.95, WRV = 5900%.

Claims

What is claimed is:
1. A process for preparing particles of microcrystalline chitosan, preferably in a form suitable for providing plant care benefits, which process comprises:
A) forming an aqueous solution containing at least 0.001% by weight of chitosan, which solution further contains organic or inorganic acids and/or salts of said acids in an amount sufficient to maintain said solution at a pH which is low enough to completely dissolve said chitosan;
B) partially neutralizing said aqueous solution by adding a neutralizing agent while subjecting said aqueous solution to shear agitation, which neutralizing agent addition and agitation is sufficient to convert said solution into a continuous gel phase having a pH of from 5.0 to 6.9;
C) maintaining the neutralized gel formed in Step B) under shear agitation for a period of at least 10 seconds after said gel has been formed in order to homogenize said gel phase; and subsequently
D) further neutralizing said homogenized gel phase formed in Step C) by addition of additional neutralizing agent sufficient to raise the pH within said homogenized gel phase above 6.9, preferably above 7.3, with continued shear agitation to an extent which is sufficient to form a gel-like suspension of discrete particles of microcrystalline chitosan.
2. A process for preparing chitosan particles which are activated, preferably to render such particles suitable for providing plant care benefits, which process comprises:
A) forming an aqueous solution containing from 0.01% to 10.0% by weight of chitosan by combining a chitosan source with water under agitation and dropping the pH of said combination by adding an acid in an amount sufficient to completely solubilize said chitosan; B) filtering said solution in order to remove insoluble matter therefrom;
C) partially neutralizing said filtered aqueous solution by adding a neutralizing agent while subjecting said aqueous solution to shear agitation, which neutralizing agent addition and agitation are sufficient to convert said solution into a continuous gel phase having a pH of from 5.0 to 6.9;
D) maintaining the neutralized gel formed in Step C) under shear agitation for a period of at least 10 seconds after said gel has been formed in order to homogenize said gel; and subsequently
E) further neutralizing said homogenized gel phase formed in Step D) by addition under continued shear agitation of additional neutralizing agent sufficient to raise the pH within said homogenized gel phase above 6.9, preferably above 7.3;
F) continuing agitation of said homogenized gel phase for at least 10 seconds
. after the elevated pH is reached in order to form a gel-like suspension of discrete particles of activated chitosan; and thereafter
G) washing said gel-like suspension of activated chitosan particles.
3. A process according to Claim 2 wherein the gel-like suspension produced in Step F) is washed in Step G) with water to remove water-soluble salts from the suspension.
4. A process according to any of Claims 1 to 3 wherein the initial aqueous solution of chitosan contains an acid selected from the group consisting of acetic acid, lactic acid, salicylic acid and hydrochloric acid.
5. A process according to any of Claims 1 to 4 wherein the neutralizing agent utilized in the process is selected from the group consisting of sodium, potassium and ammonium hydroxides which are used in the form of aqueous solutions comprising from 0.01% to 2% by weight of the neutralizing agent.
6. A process according to any of Claims 1 to 5 wherein shear agitation utilized during the partial neutralization step is applied to the extent of from 10 to 1000 sec"1.
7. A process according to any of Claims 1 to 6 wherein shear agitation utilized during the homogenization step is applied to the extent of from 100 to 5000 sec"1 and lasts for a period of from 1 to 60 minutes.
8. A process according to any of Claims 1 to 7 which is carried out in a batch- wise manner.
9. A process according to any of Claims 1 to 7 which is carried out in a continuous manner.
10. A suspension of chitosan particles prepared by the process of any of Claims 1 to 9 wherein said chitosan particles range in size from 2 to 20 μm and have a water solubility of at least 90% at pH of 6 after 24 hours.
11. A suspension of chitosan particles prepared by the process of any of Claims 1 to 9 wherein said chitosan particles have a Water Retention Value which is higher than that of the chitosan starting material.
12. A suspension of chitosan particles according to Claim 11 wherein said chitosan particles have a Water Retention Value of at least 1000%, preferably at least 5000%).
PCT/US2001/015182 2000-05-12 2001-05-10 Process for preparing chitosan particles WO2001087988A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2001585205A JP2004501235A (en) 2000-05-12 2001-05-10 Preparation process of chitosan particles
AU2001263046A AU2001263046A1 (en) 2000-05-12 2001-05-10 Process for preparing chitosan particles
EP01937295A EP1280829A1 (en) 2000-05-12 2001-05-10 Process for preparing chitosan particles
CA002407584A CA2407584A1 (en) 2000-05-12 2001-05-10 Process for preparing chitosan particles
US10/278,534 US6740752B2 (en) 2000-05-12 2002-10-23 Process for preparing chitosan particles

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL34013200A PL340132A1 (en) 2000-05-12 2000-05-12 Method of obtaining modified microcrystalline chitosamine
PLP.340132 2000-05-12

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/278,534 Continuation US6740752B2 (en) 2000-05-12 2002-10-23 Process for preparing chitosan particles

Publications (1)

Publication Number Publication Date
WO2001087988A1 true WO2001087988A1 (en) 2001-11-22

Family

ID=20076628

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/015182 WO2001087988A1 (en) 2000-05-12 2001-05-10 Process for preparing chitosan particles

Country Status (6)

Country Link
EP (1) EP1280829A1 (en)
JP (1) JP2004501235A (en)
AU (1) AU2001263046A1 (en)
CA (1) CA2407584A1 (en)
PL (1) PL340132A1 (en)
WO (1) WO2001087988A1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1280410A1 (en) * 2000-05-12 2003-02-05 The Procter & Gamble Company Chitosan polymer compositions for plant care
WO2003042251A1 (en) * 2001-11-09 2003-05-22 The Procter & Gamble Company Chitosan compositions
WO2003066682A1 (en) * 2002-02-07 2003-08-14 Abbott Laboratories De Costa Rica Ltd Method for deproteinization of chitosan
FR2843965A1 (en) * 2002-08-28 2004-03-05 Rhodia Chimie Sa New powder particles based on associative, amphiphilic polysaccharide, preferably alginate, useful for encapsulation of peptides, polypeptides or proteins, e.g. enzymes for use in detergents
WO2004078790A1 (en) * 2003-03-06 2004-09-16 The Procter & Gamble Company Chitosan powder
KR100481793B1 (en) * 2002-05-24 2005-04-11 주식회사 만나피아 A manufacturing method of water soluble chitosan
WO2006067626A2 (en) * 2004-12-20 2006-06-29 Carbgraft Ab Chitosan compositions
US7776840B2 (en) 2007-02-21 2010-08-17 Cutanea Life Sciences, Inc. Methods of use of biomaterial and injectable implant containing biomaterial
KR101402832B1 (en) * 2006-02-24 2014-06-19 커터니아 라이프 사이언시즈 인코포레이티드 Biomaterial, injectable implant comprising it, its method of preparation and its uses
RU2548003C1 (en) * 2013-12-17 2015-04-10 Константин Сергеевич Назаров Method of producing chitosan derivative, having amphiphilic properties
CN113980154A (en) * 2021-11-19 2022-01-28 南开大学 High-strength chitosan ligand exchange resin and preparation method thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4813054B2 (en) * 2004-12-21 2011-11-09 学校法人 関西大学 Neutral chitosan hydrogel and process for producing the same
KR102661511B1 (en) * 2021-10-20 2024-04-26 서울대학교산학협력단 Chitosan carrier synthesis apparatus and method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL125995B2 (en) * 1981-02-27 1983-06-30 Process for preparing chitosan of enlarged internal surface
WO1991000298A1 (en) * 1989-06-30 1991-01-10 Firextra Oy Method for continuous manufacture of microcrystalline chitosan
WO2001019187A1 (en) * 1999-09-14 2001-03-22 Instytut Włòkien Chemicznych Agent for protecting plants against diseases

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL125995B2 (en) * 1981-02-27 1983-06-30 Process for preparing chitosan of enlarged internal surface
WO1991000298A1 (en) * 1989-06-30 1991-01-10 Firextra Oy Method for continuous manufacture of microcrystalline chitosan
FI83426B (en) * 1989-06-30 1991-03-28 Firextra Oy FOERFARANDE FOER KONTINUERLIG FRAMSTAELLNING AV MICROCRYSTALLINE KITOSAN.
WO2001019187A1 (en) * 1999-09-14 2001-03-22 Instytut Włòkien Chemicznych Agent for protecting plants against diseases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE CHEMABS CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US;; STRUSZCZYK H. ET AL.: "Chitosan of enlarged internal surface", XP002175990 *
STRUSZCZYK H.: "Microcrystalline chitosan. I. Preparation and properties of microcrystalline chitosan.", JOURNAL OF APPLIED POLYMER SCIENCE, vol. 33, 1987, pages 177 - 189, XP002175989 *

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1280410A1 (en) * 2000-05-12 2003-02-05 The Procter & Gamble Company Chitosan polymer compositions for plant care
WO2003042251A1 (en) * 2001-11-09 2003-05-22 The Procter & Gamble Company Chitosan compositions
US6638918B2 (en) 2001-11-09 2003-10-28 The Procter & Gamble Company Chitosan compositions
WO2003066682A1 (en) * 2002-02-07 2003-08-14 Abbott Laboratories De Costa Rica Ltd Method for deproteinization of chitosan
KR100481793B1 (en) * 2002-05-24 2005-04-11 주식회사 만나피아 A manufacturing method of water soluble chitosan
FR2843965A1 (en) * 2002-08-28 2004-03-05 Rhodia Chimie Sa New powder particles based on associative, amphiphilic polysaccharide, preferably alginate, useful for encapsulation of peptides, polypeptides or proteins, e.g. enzymes for use in detergents
WO2004078790A1 (en) * 2003-03-06 2004-09-16 The Procter & Gamble Company Chitosan powder
WO2006067626A3 (en) * 2004-12-20 2006-08-31 Carbgraft Ab Chitosan compositions
WO2006067626A2 (en) * 2004-12-20 2006-06-29 Carbgraft Ab Chitosan compositions
KR101402832B1 (en) * 2006-02-24 2014-06-19 커터니아 라이프 사이언시즈 인코포레이티드 Biomaterial, injectable implant comprising it, its method of preparation and its uses
US9339590B2 (en) * 2006-02-24 2016-05-17 Cutanea Life Sciences, Inc. Biomaterial, injectable implant comprising it, its method of preparation and its uses
US7776840B2 (en) 2007-02-21 2010-08-17 Cutanea Life Sciences, Inc. Methods of use of biomaterial and injectable implant containing biomaterial
US9029350B2 (en) 2007-02-21 2015-05-12 Cutanea Life Sciences, Inc. Methods of use of biomaterial and injectable implant containing biomaterial
RU2548003C1 (en) * 2013-12-17 2015-04-10 Константин Сергеевич Назаров Method of producing chitosan derivative, having amphiphilic properties
CN113980154A (en) * 2021-11-19 2022-01-28 南开大学 High-strength chitosan ligand exchange resin and preparation method thereof
CN113980154B (en) * 2021-11-19 2022-12-02 南开大学 High-strength chitosan ligand exchange resin and preparation method thereof

Also Published As

Publication number Publication date
PL340132A1 (en) 2001-11-19
CA2407584A1 (en) 2001-11-22
JP2004501235A (en) 2004-01-15
AU2001263046A1 (en) 2001-11-26
EP1280829A1 (en) 2003-02-05

Similar Documents

Publication Publication Date Title
US6310188B1 (en) Method for producing chitin or chitosan
WO2001087988A1 (en) Process for preparing chitosan particles
JPS638205B2 (en)
US6740752B2 (en) Process for preparing chitosan particles
CN105732842B (en) A kind of high bioactivity chitin and preparation method thereof
JPS63225602A (en) Easily soluble chitosan
JP4813054B2 (en) Neutral chitosan hydrogel and process for producing the same
JPH01287103A (en) Production of fine powder of hyaluronic acid or sodium hyaluronate
JP2537421B2 (en) Hydroxypropylated deacetylated chitin and method for producing the same
Hasan et al. Preparation of chitin and chitosan
JPS62184002A (en) Production of low-molecular weight water-soluble chitosan
JPH01185301A (en) Manufacture of low-molecular chitosan
US20050159593A1 (en) Method for deproteinization of chitosan
JP2002306090A (en) Curdlan/chitosan-containing composition and method for producing the same
KR100741531B1 (en) The preparation method of carrier comprising polymer electrolyte complex
JPS6363701A (en) Production of water-soluble chitosan of lowered molecular weight
JP2000027027A (en) Polymer composite material and its production
JP3803123B2 (en) Water-soluble partially deacetylated chitin and process for producing the same
JPS63182304A (en) Microcrystalling chitosan and its manufacture
KR100252704B1 (en) Method of making n,o-carboxy methyl chitosan with high purity crystallization and a method of controlling a molecular weight of water-soluble chitosan
CN102634074B (en) Chitin pulp and production method thereof
JP2008101079A (en) Manufacturing method for chitosan fine particle
JPH04108734A (en) Cholesterol lowering agent
WO2010061454A1 (en) Process for production of high-purity chitin slurry
KR20200056890A (en) Stabilizing of vitamin C derivatives and cosmetic composition containing the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 10278534

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2407584

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001937295

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001937295

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001937295

Country of ref document: EP